|
Market Analysis Reports of PTC299
|
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL-042, Pulmozyme, Pyramax, Pyridostigmine ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL-042, Pulmozyme, Pyramax, Pyridostigmine ...
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review ... ; PTC596 for the treatment of leiomyosarcoma; PTC299 for the treatment of acute myelogenous ...
|
|
|